Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    BioNTech SE

    NASDAQ: BNTX · Real-Time Price · USD
    106.58
    1.66 (1.58%)
    At close: Jun 13, 2025, 3:59 PM
    106.56
    -0.02%
    After-hours: Jun 13, 2025, 05:51 PM EDT

    BioNTech SE Statistics

    Share Statistics

    BioNTech SE has 240.39M shares outstanding. The number of shares has increased by 0.94% in one year.

    Shares Outstanding

    n/a
    		 240.39M

    Shares Change (YoY)

    n/a
    		 0.94%

    Shares Change (QoQ)

    n/a
    		 0.1%

    Owned by Institutions (%)

    n/a
    		 21.17%

    Shares Floating

    n/a
    		 236.7M

    Failed to Deliver (FTD) Shares

    n/a
    		 70,957

    FTD / Avg. Volume

    n/a
    		 5.85%

    Short Selling Information

    The latest short interest is 5.2M, so 2.16% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 5.2M

    Short % of Shares Out

    n/a
    		 2.16%

    Short % of Float

    n/a
    		 5.63%

    Short Ratio (days to cover)

    n/a
    		 6.15

    Valuation Ratios

    The PE ratio is -39.73 and the forward PE ratio is -18.47. BioNTech SE's PEG ratio is 0.23.

    PE Ratio

    n/a
    		 -39.73

    Forward PE

    n/a
    		 -18.47

    PS Ratio

    n/a
    		 9.61

    Forward PS

    n/a
    		 6.7

    PB Ratio

    n/a
    		 1.36

    P/FCF Ratio

    n/a
    		 -108.05

    PEG Ratio

    n/a
    		 0.23
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for BioNTech SE.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 7.45, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 7.45

    Quick Ratio

    n/a
    		 7.34

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.69

    Debt / FCF

    n/a
    		 -1.04

    Interest Coverage

    n/a
    		 -104.31

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $406,246.31

    Profits Per Employee

    n/a
    		 $-98,242.76

    Employee Count

    n/a
    		 6,772

    Asset Turnover

    n/a
    		 0.12

    Inventory Turnover

    n/a
    		 1.91

    Taxes

    Income Tax

    n/a
    		 -12.4M

    Effective Tax Rate

    n/a
    		 1.83%

    Stock Price Statistics

    The stock price has increased by 15.75% in the last 52 weeks. The beta is 1.28, so BioNTech SE's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.28

    52-Week Price Change

    n/a
    		 15.75%

    50-Day Moving Average

    n/a
    		 100.48

    200-Day Moving Average

    n/a
    		 108.78

    Relative Strength Index (RSI)

    n/a
    		 54.25

    Average Volume (20 Days)

    n/a
    		 1,213,734

    Income Statement

    In the last 12 months, BioNTech SE had revenue of 2.75B and earned -665.3M in profits. Earnings per share was -2.77.

    Revenue

    n/a
    		 2.75B

    Gross Profit

    n/a
    		 2.21B

    Operating Income

    n/a
    		 -1.31B

    Net Income

    n/a
    		 -665.3M

    EBITDA

    n/a
    		 -367.1M

    EBIT

    n/a
    		 -665.1M

    Earnings Per Share (EPS)

    n/a
    		 -2.77
    Full Income Statement

    Balance Sheet

    The company has 9.76B in cash and 254.2M in debt, giving a net cash position of 9.51B.

    Cash & Cash Equivalents

    n/a
    		 9.76B

    Total Debt

    n/a
    		 254.2M

    Net Cash

    n/a
    		 9.51B

    Retained Earnings

    n/a
    		 19.1B

    Total Assets

    n/a
    		 21.18B

    Working Capital

    n/a
    		 14.09B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 207.7M and capital expenditures -452.3M, giving a free cash flow of -244.6M.

    Operating Cash Flow

    n/a
    		 207.7M

    Capital Expenditures

    n/a
    		 -452.3M

    Free Cash Flow

    n/a
    		 -244.6M

    FCF Per Share

    n/a
    		 -1.02
    Full Cash Flow Statement

    Margins

    Gross margin is 80.32%, with operating and profit margins of -47.77% and -24.18%.

    Gross Margin

    n/a
    		 80.32%

    Operating Margin

    n/a
    		 -47.77%

    Pretax Margin

    n/a
    		 -24.63%

    Profit Margin

    n/a
    		 -24.18%

    EBITDA Margin

    n/a
    		 -13.34%

    EBIT Margin

    n/a
    		 -47.77%

    FCF Margin

    n/a
    		 -8.89%

    Dividends & Yields

    BNTX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for BNTX is $141.5, which is 32.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $141.5

    Price Target Difference

    n/a
    		 32.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 16
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 8.28

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist